These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9143346

  • 21. Failure of GLP-1(7-36)amide to affect glycogenesis in rat skeletal muscle.
    Fürnsinn C, Ebner K, Waldhäusl W.
    Diabetologia; 1995 Jul; 38(7):864-7. PubMed ID: 7556991
    [Abstract] [Full Text] [Related]

  • 22. Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2.
    Schepp W, Schmidtler J, Riedel T, Dehne K, Schusdziarra V, Holst JJ, Eng J, Raufman JP, Classen M.
    Eur J Pharmacol; 1994 Oct 14; 269(2):183-91. PubMed ID: 7851494
    [Abstract] [Full Text] [Related]

  • 23. Rat gastric somatostatin and gastrin release: interactions of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide.
    Eissele R, Bothe-Sandfort E, Göke B, Eng J, Arnold R, Koop H.
    Life Sci; 1994 Oct 14; 55(8):629-34. PubMed ID: 7913983
    [Abstract] [Full Text] [Related]

  • 24. GLP-1 (7-36) amide: effects on glucose transport and metabolism in rat adipose tissue.
    Perea A, Viñambres C, Clemente F, Villanueva-Peñacarrillo ML, Valverde I.
    Horm Metab Res; 1997 Sep 14; 29(9):417-21. PubMed ID: 9370107
    [Abstract] [Full Text] [Related]

  • 25. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J, Ding WG, Barg S, Renström E, Rorsman P.
    Pflugers Arch; 1997 Sep 14; 434(5):515-24. PubMed ID: 9242714
    [Abstract] [Full Text] [Related]

  • 26. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor.
    Montrose-Rafizadeh C, Yang H, Rodgers BD, Beday A, Pritchette LA, Eng J.
    J Biol Chem; 1997 Aug 22; 272(34):21201-6. PubMed ID: 9261127
    [Abstract] [Full Text] [Related]

  • 27. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39).
    Fehmann HC, Jiang J, Schweinfurth J, Wheeler MB, Boyd AE, Göke B.
    Peptides; 1994 Aug 22; 15(3):453-6. PubMed ID: 7937318
    [Abstract] [Full Text] [Related]

  • 28. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C, Bailbé D, Meile MJ, Kergoat M, Portha B.
    Diabetes; 2001 Jul 22; 50(7):1562-70. PubMed ID: 11423477
    [Abstract] [Full Text] [Related]

  • 29. Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.
    Wang L, Guo F, Wei S, Zhao R.
    Peptides; 2011 Jun 22; 32(6):1313-9. PubMed ID: 21453734
    [Abstract] [Full Text] [Related]

  • 30. The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor.
    Nishizawa M, Nakabayashi H, Kawai K, Ito T, Kawakami S, Nakagawa A, Niijima A, Uchida K.
    J Auton Nerv Syst; 2000 Apr 12; 80(1-2):14-21. PubMed ID: 10742535
    [Abstract] [Full Text] [Related]

  • 31. Glucagon-like peptide-1(7-37) does not stimulate either hepatic glycogenolysis or ketogenesis.
    Murayama Y, Kawai K, Suzuki S, Ohashi S, Yamashita K.
    Endocrinol Jpn; 1990 Apr 12; 37(2):293-7. PubMed ID: 2171922
    [Abstract] [Full Text] [Related]

  • 32. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.
    Moens K, Flamez D, Van Schravendijk C, Ling Z, Pipeleers D, Schuit F.
    Diabetes; 1998 Jan 12; 47(1):66-72. PubMed ID: 9421376
    [Abstract] [Full Text] [Related]

  • 33. A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew).
    Chan SW, Lin G, Yew DT, Rudd JA.
    Eur J Pharmacol; 2011 Oct 01; 668(1-2):340-6. PubMed ID: 21756894
    [Abstract] [Full Text] [Related]

  • 34. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.
    Villanueva-Peñacarrillo ML, Puente J, Redondo A, Clemente F, Valverde I.
    Endocrine; 2001 Jul 01; 15(2):241-8. PubMed ID: 11720253
    [Abstract] [Full Text] [Related]

  • 35. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA.
    Diabetologia; 2002 Oct 01; 45(10):1410-5. PubMed ID: 12378382
    [Abstract] [Full Text] [Related]

  • 36. Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.
    González N, Acitores A, Sancho V, Valverde I, Villanueva-Peñacarrillo ML.
    Regul Pept; 2005 Mar 30; 126(3):203-11. PubMed ID: 15664668
    [Abstract] [Full Text] [Related]

  • 37. Glucagon-like peptide-1(7-36)amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes.
    Miki H, Namba M, Nishimura T, Mineo I, Matsumura T, Miyagawa J, Nakajima H, Kuwajima M, Hanafusa T, Matsuzawa Y.
    Biochim Biophys Acta; 1996 Jun 13; 1312(2):132-6. PubMed ID: 8672535
    [Abstract] [Full Text] [Related]

  • 38. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.
    Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH.
    J Pharmacol Exp Ther; 2002 Sep 13; 302(3):881-8. PubMed ID: 12183643
    [Abstract] [Full Text] [Related]

  • 39. Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.
    Sancho V, Trigo MV, González N, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML.
    J Mol Endocrinol; 2005 Aug 13; 35(1):27-38. PubMed ID: 16087719
    [Abstract] [Full Text] [Related]

  • 40. Glucagon-like peptide-1 is a physiological incretin in rat.
    Wang Z, Wang RM, Owji AA, Smith DM, Ghatei MA, Bloom SR.
    J Clin Invest; 1995 Jan 13; 95(1):417-21. PubMed ID: 7814643
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.